Literature DB >> 11222471

Signaling pathways responsible for fetal gene induction in the failing human heart: evidence for altered thyroid hormone receptor gene expression.

K Kinugawa1, W A Minobe, W M Wood, E C Ridgway, J D Baxter, R C Ribeiro, M F Tawadrous, B A Lowes, C S Long, M R Bristow.   

Abstract

BACKGROUND: We have previously demonstrated that changes in myosin heavy chain (MHC) isoforms that occur in failing human hearts resemble the pattern produced in rodent myocardium in response to hypothyroidism. Because thyroid hormone status is usually within normal limits in these patients, we hypothesized that failing/hypertrophied human myocardium might have a defect in thyroid hormone signaling due to alterations in expression of thyroid hormone receptors (TRs). METHODS AND
RESULTS: To examine this hypothesis, we used RNase protection assay to measure mRNA levels of TRs in failing left ventricles that exhibited a fetal pattern of gene expression, ie, decreased expression of alpha-MHC with increased beta-MHC expression compared with left ventricles from age-matched controls. We detected expression of TR-alpha(1), -alpha(2), and -beta(1) isoforms in human left ventricles. In failing left ventricles, TR-alpha(1) was downregulated, whereas TR-alpha(2), a splice variant that does not bind thyroid hormone but inhibits responses to liganded TRs, was increased. Expression levels of TR-beta(1) did not differ significantly between the 2 groups. According to linear regression analysis, expression levels of TR-alpha(1) and -alpha(2) were positively and negatively correlated with those of alpha-MHC, respectively.
CONCLUSIONS: We conclude that decreases in TR-alpha(1) and increases in TR-alpha(2) may lead to local attenuation of thyroid hormone signaling in the failing human heart and that the resulting tissue-specific hypothyroidism is a candidate for the molecular mechanism that induces fetal gene expression in the failing human ventricle.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222471     DOI: 10.1161/01.cir.103.8.1089

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  34 in total

Review 1.  Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.

Authors:  Nicole T Feric; Milica Radisic
Journal:  Adv Drug Deliv Rev       Date:  2015-05-05       Impact factor: 15.470

2.  Cardiac angiotensin receptor expression in hypothyroidism: back to fetal gene programme?

Authors:  Giuseppe Vergaro; Michele Emdin
Journal:  J Physiol       Date:  2007-11-01       Impact factor: 5.182

Review 3.  The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence.

Authors:  E Galli; A Pingitore; G Iervasi
Journal:  Heart Fail Rev       Date:  2008-12-27       Impact factor: 4.214

4.  Therapeutic Molecular Phenotype of β-Blocker-Associated Reverse-Remodeling in Nonischemic Dilated Cardiomyopathy.

Authors:  David P Kao; Brian D Lowes; Edward M Gilbert; Wayne Minobe; L Elaine Epperson; Leslie K Meyer; Debra A Ferguson; Ann Kirkpatrick Volkman; Ronald Zolty; C Douglas Borg; Robert A Quaife; Michael R Bristow
Journal:  Circ Cardiovasc Genet       Date:  2015-01-30

Review 5.  Thyroid hormone and heart failure.

Authors:  Ursula Maria Schmidt-Ott; Deborah Davis Ascheim
Journal:  Curr Heart Fail Rep       Date:  2006-09

6.  Divergent regulation of cardiac KCND3 potassium channel expression by the thyroid hormone receptors alpha1 and beta1.

Authors:  Natig Gassanov; Fikret Er; Guido Michels; Naufal Zagidullin; Mathias C Brandt; Uta C Hoppe
Journal:  J Physiol       Date:  2009-01-26       Impact factor: 5.182

7.  Thyroid hormone receptor-beta is associated with coronary angiogenesis during pathological cardiac hypertrophy.

Authors:  Ayako Makino; Jorge Suarez; Hong Wang; Darrell D Belke; Brian T Scott; Wolfgang H Dillmann
Journal:  Endocrinology       Date:  2008-12-12       Impact factor: 4.736

Review 8.  Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes.

Authors:  Fikru B Bedada; Matthew Wheelwright; Joseph M Metzger
Journal:  Biochim Biophys Acta       Date:  2015-11-11

9.  Low-dose T₃ replacement restores depressed cardiac T₃ levels, preserves coronary microvasculature and attenuates cardiac dysfunction in experimental diabetes mellitus.

Authors:  Nathan Y Weltman; Kaie Ojamaa; Evelyn H Schlenker; Yue-Feng Chen; Riccardo Zucchi; Alessandro Saba; Daria Colligiani; Viswanathan Rajagopalan; Christine J Pol; A Martin Gerdes
Journal:  Mol Med       Date:  2014-05-01       Impact factor: 6.354

Review 10.  Cardiomyocyte-specific inactivation of thyroid hormone in pathologic ventricular hypertrophy: an adaptative response or part of the problem?

Authors:  Christine J Pol; Alice Muller; Warner S Simonides
Journal:  Heart Fail Rev       Date:  2010-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.